↓ Skip to main content

Experiences with Adverse Drug Reaction Reporting by Patients

Overview of attention for article published in Drug Safety, November 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
policy
2 policy sources
facebook
1 Facebook page

Citations

dimensions_citation
115 Dimensions

Readers on

mendeley
118 Mendeley
Title
Experiences with Adverse Drug Reaction Reporting by Patients
Published in
Drug Safety, November 2012
DOI 10.2165/11594320-000000000-00000
Pubmed ID
Authors

Florence van Hunsel, Linda Härmark, Shanthi Pal, Sten Olsson, Kees van Grootheest

Abstract

Patients are important stakeholders in pharmacovigilance; however, little formal evaluation has been undertaken of existing patient reporting schemes within and outside Europe. If patient reporting is to be recognized as beneficial for pharmacovigilance and further optimized, methodology and best practice must be internationally shared and promoted.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 118 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Malaysia 1 <1%
United States 1 <1%
Nigeria 1 <1%
Unknown 114 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 28 24%
Researcher 16 14%
Student > Ph. D. Student 16 14%
Student > Bachelor 9 8%
Student > Postgraduate 5 4%
Other 21 18%
Unknown 23 19%
Readers by discipline Count As %
Medicine and Dentistry 33 28%
Pharmacology, Toxicology and Pharmaceutical Science 25 21%
Nursing and Health Professions 7 6%
Computer Science 4 3%
Agricultural and Biological Sciences 3 3%
Other 18 15%
Unknown 28 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 August 2023.
All research outputs
#1,848,533
of 25,374,647 outputs
Outputs from Drug Safety
#181
of 1,852 outputs
Outputs of similar age
#15,874
of 285,244 outputs
Outputs of similar age from Drug Safety
#53
of 812 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,852 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.9. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 285,244 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 812 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.